| Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa MJ Van der Werf, SJ De Vlas, S Brooker, CWN Looman, NJD Nagelkerke, ... Acta tropica 86 (2-3), 125-139, 2003 | 1223 | 2003 |
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic … M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ... The Lancet Public Health 1 (1), e8-e17, 2016 | 371 | 2016 |
| Underestimation of Schistosoma mansoni prevalences SJ De Vlas, B Gryseels Parasitology Today 8 (8), 274-277, 1992 | 321 | 1992 |
| Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications TA Abeku, GJ Van Oortmarssen, G Borsboom, SJ de Vlas, JDF Habbema Acta tropica 87 (3), 331-340, 2003 | 279 | 2003 |
| Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence B Gryseels, A Mbaye, SJ De Vlas, FF Stelma, F Guisse, L Van Lieshout, ... Tropical medicine & international health 6 (11), 864-873, 2001 | 276 | 2001 |
| What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? EL Korenromp, MK Sudaryo, SJ de Vlas, RH Gray, NK Sewankambo, ... International journal of STD & AIDS 13 (2), 91-101, 2002 | 265 | 2002 |
| Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A MD Spring, JF Cummings, CF Ockenhouse, S Dutta, R Reidler, E Angov, ... PloS one 4 (4), e5254, 2009 | 259 | 2009 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 248 | 2014 |
| Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission AL Ouedraogo, T Bousema, P Schneider, SJ de Vlas, E Ilboudo-Sanogo, ... PloS one 4 (12), e8410, 2009 | 247 | 2009 |
| Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission NJD Nagelkerke, P Jha, SJ Vlas, EL Korenromp, S Moses, JF Blanchard, ... Bulletin of the World Health Organization 80, 89-96, 2002 | 243 | 2002 |
| Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal A Danso-Appiah, SJ De Vlas Trends in parasitology 18 (3), 125-129, 2002 | 241 | 2002 |
| Environmental factors contributing to the spread of H5N1 avian influenza in mainland China LQ Fang, SJ de Vlas, S Liang, CWN Looman, P Gong, B Xu, L Yan, ... PloS one 3 (5), e2268, 2008 | 232 | 2008 |
| Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa EL Korenromp, BG Williams, SJ De Vlas, E Gouws, CF Gilks, PD Ghys, ... Emerging infectious diseases 11 (9), 1410, 2005 | 220 | 2005 |
| The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ... Aids 26, S19-S30, 2012 | 209 | 2012 |
| Socioeconomic inequalities in neglected tropical diseases: a systematic review TAJ Houweling, HE Karim-Kos, MC Kulik, WA Stolk, JA Haagsma, ... PLoS neglected tropical diseases 10 (5), e0004546, 2016 | 198 | 2016 |
| Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa NJD Nagelkerke, S Moses, SJ de Vlas, RC Bailey BMC infectious diseases 7 (1), 16, 2007 | 187 | 2007 |
| The economic impact of SARS in Beijing, China P Beutels, N Jia, QY Zhou, R Smith, WC Cao, SJ De Vlas Tropical Medicine & International Health 14, 85-91, 2009 | 184 | 2009 |
| Comparison of the Kato-Katz technique, hatching test and indirect hemagglutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China JM Yu, SJ De Vlas, QW Jiang, B Gryseels Parasitology international 56 (1), 45-49, 2007 | 175 | 2007 |
| Global elimination of leprosy by 2020: are we on track? DJ Blok, SJ De Vlas, JH Richardus Parasites & vectors 8 (1), 548, 2015 | 170 | 2015 |
| Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ... PLoS medicine 10 (10), e1001534, 2013 | 168 | 2013 |
